# CAPERE Thrombectomy System Post-Market Clinical Follow Up Study

> **NCT03869645** · — · TERMINATED · sponsor: **Medtronic Endovascular** · enrollment: 18 (actual)

## Conditions studied

- Observational Study

## Interventions

- **DEVICE:** CAPERE Thrombectomy System

## Key facts

- **NCT ID:** NCT03869645
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-01
- **Primary completion:** 2020-08-26
- **Final completion:** 2020-08-26
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Change in Sponsor
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03869645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03869645, "CAPERE Thrombectomy System Post-Market Clinical Follow Up Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03869645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*